Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs Ravia Health

Eve
Graded #212

Higher grade

vs+6.799999999999997
Ravia Health
Graded #347

Lower grade

The verdict

Eve takes it — 66/100 to 59.2/100.

Eve grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEve +9
54
45
Dose & formulationEve +35
88
53
Clinical oversightRavia Health +8
79
87
Labs & monitoringRavia Health +13
52
65
FulfillmentEve +9
67
58
Contract termsEven
41
41
Eve · left barRavia Health · right bar

The numbers

MetricEveRavia Health
WeighScore66/10059.2/100
GradeCC
Scorecard rank#212#347
Semaglutide$195/mo (compounded)Not disclosed
Tirzepatide$195/mo (compounded)Not disclosed
CoverageCoverage not published1 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
Eve

Graded #212 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated
Ravia Health

Graded #347 · C

Strengths

  • Integrative psychiatry model combines GLP-1 weight-loss with mental health and metabolic care under one board-certified NP provider
  • Founded by Dr. Raashida Portier (DNP, PMHNP-BC, FNP-BC); named clinician with dual board certifications in psychiatry and family medicine
  • Membership-supported ongoing care from $49/month provides medication management structure with consistent follow-up
  • Labs and metabolic workup available as part of integrative psychiatry model; lab testing noted in weight-loss program
  • Weight-loss page claims nationwide availability via Lyv Health partnership for eligible patients

Where it loses points

  • GLP-1 medication pricing fully gated — not disclosed until consultation; compounded vs. brand status unclear on public pages
  • Primarily a psychiatric practice — weight loss is a secondary service, not the core offering or brand identity
  • Core services explicitly Florida-only; nationwide weight-loss claim relies on Lyv Health partnership with unverified state coverage
  • No LegitScript certification or third-party accreditation found on public pages
  • Small single-provider practice with no published outcomes data or external reviews available

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard